Intracranial Arteriosclerosis clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis

    “Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”

    open to eligible people ages 30 years and up

    The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.

    Sacramento, California and other locations

Last updated: